Indeed, it was demonstrated that both eEF2-KMT and the eEF1A MTase METTL13 were required for efficient growth of Ras-driven cancer, and that METTL13 depletion rendered the cancer cells hypersensitive towards other cancer drugs (45,135). Here, METTL13 is linked to cancer.